Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions
- 1 November 2004
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 34 (11), 774-781
- https://doi.org/10.1111/j.1365-2362.2004.01418.x
Abstract
Protein factors accumulating in sera of patients with end-stage renal disease (ESRD) that interfere with the nonspecific immune response by inhibiting essential functions of polymorphonuclear leucocytes (PMNLs) have previously been described. No such factor has been isolated from acute renal failure (ARF) patients to date. Using a three-step chromatographic procedure involving ion exchange, size exclusion and hydrophobic interaction chromatography we purified the apo- and holo-form of retinol binding protein (RBP) from high-flux dialyser (polyacrylonitrile; AN69) ultrafiltrates of patients with ARF. Their effect on the chemotaxis of PMNLs isolated from healthy donors was determined by the under-agarose method. Whole-blood assays applying flow cytometry were used to assess phagocytosis and the oxidative metabolism of PMNLs. Apoptosis was assessed by determining the DNA content using propidium iodide. Isolated apo- and holo-forms of RBP were truncated on their C-terminus as determined by mass spectrometry. All isolates significantly inhibited the chemotactic movement of PMNLs obtained from healthy donors and the PMNL oxidative metabolism stimulated by E. coli. These effects were concentration dependent. Retinol binding protein had no influence on the PMNL oxidative metabolism stimulated by PMA and on PMNL phagocytosis. Commercially available RBP isolated from urine influenced PMNL functions in the same way. Inhibition of p38 mitogen-activated protein kinase (MAPK) by SB203580 significantly attenuated the phagocytosis-induced respiratory burst and RBP did not lead to a further decrease. Polymorphonuclear leucocyte apoptosis was significantly inhibited by RBP. The apo- and holo-forms of RBP isolated from the ultrafiltrate of ARF patients inhibit PMNL chemotaxis, oxidative metabolism and apoptosis. Therefore, RBP may be considered a uraemic toxin contributing to a disturbed immune defence.Keywords
This publication has 22 references indexed in Scilit:
- Activation of Rac2 and Cdc42 on Fc and complement receptor ligation in human neutrophilsJournal of Leukocyte Biology, 2003
- Activation of SHIP by NADPH Oxidase-stimulated Lyn Leads to Enhanced Apoptosis in NeutrophilsJournal of Biological Chemistry, 2002
- Cystatin C, β2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinineJournal of Pharmaceutical and Biomedical Analysis, 2001
- The Structure of Human Retinol-Binding Protein (RBP) with Its Carrier Protein Transthyretin Reveals an Interaction with the Carboxy Terminus of RBP,Biochemistry, 1999
- Extra- and Intracellular Transport of Retinoids: A ReappraisalHormone Research, 1996
- CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation.The Journal of cell biology, 1994
- Phagocyte recognition of cells undergoing apoptosisImmunology Today, 1993
- Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.JCI Insight, 1989
- Retinol-binding protein in human serum: Conformational changes induced by retinoic acid bindingBiochemical and Biophysical Research Communications, 1987
- Retinol binding protein in serum and in urine of glomerular and tubular nephropathiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1976